Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
PCRX: Pacira BioSciences, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
PCRX
The Story
PCRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
No data
Revenue growth
+3.9% / yr
Operating margin
3.1%
ROIC
0.8%
Financially safe
Adequate
Debt / equity
0.63×
Interest coverage
1.5×
Current ratio
4.73×
Valuation
Unrated
P/E ratio
216.3×
Pacira BioSciences, Inc.
PCRX
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Pacira BioSciences, Inc.
PCRX
NASDAQ
·
USD
·
Closed
$26.41
−2.08%
$26.41
−$0.56 (2.08%)
52W Range
86th
pctl
Volume
0.98×
avg
Mkt Cap
1.04B
USD
P/E
216.3
TTM
Div Yield
–
ann
52W Range
86th
pctl
Volume
0.98×
avg
Market Cap
1.04B
USD
P/E Ratio
216.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings